1. Home
  2. AZTA vs FTRE Comparison

AZTA vs FTRE Comparison

Compare AZTA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$17.54

Market Cap

738.4M

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.78

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
FTRE
Founded
1978
1996
Country
United States
United States
Employees
2900
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
829.3M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
AZTA
FTRE
Price
$17.54
$13.78
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$40.60
$14.06
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
$2,723,400,000.00
Revenue This Year
$6.99
N/A
Revenue Next Year
$5.98
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$15.93
$3.97
52 Week High
$41.73
$18.67

Technical Indicators

Market Signals
Indicator
AZTA
FTRE
Relative Strength Index (RSI) 36.28 60.60
Support Level N/A $8.85
Resistance Level $32.32 $18.26
Average True Range (ATR) 1.18 0.84
MACD -0.52 -0.08
Stochastic Oscillator 16.66 57.55

Price Performance

Historical Comparison
AZTA
FTRE

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: